Cook-Deegan Robert, McCormack Stephen J
Kennedy Inst Ethics J. 2019;29(1):51-66. doi: 10.1353/ken.2019.0010.
LeRoy Walters was at the center of public debate about emerging biological technologies, even as "biotechnology" began to take root. He chaired advisory panels on human gene therapy, the human genome project, and patenting DNA for the congressional Office of Technology Assessment. He chaired the subcommittee on Human Gene Therapy for NIH's Recombinant DNA Advisory Committee. He was also a regular advisor to Congress, the executive branch, and academics concerned about policy governing emerging biotechnologies. In large part due to Prof. Walters, the Kennedy Institute of Ethics was one of the primary sources of talent in bioethics, including staff who populated policy and science agencies dealing with reproductive and genetic technologies, such as NIH and OTA. His legacy lies not only in his writings, but in those people, documents, and discussions that guided biotechnology policy in the United States for three decades.
勒罗伊·沃尔特斯处于关于新兴生物技术的公众辩论的中心，即便“生物技术”才刚刚开始生根发芽。他曾担任国会技术评估办公室关于人类基因治疗、人类基因组计划以及DNA专利问题的顾问小组主席。他还担任了美国国立卫生研究院重组DNA咨询委员会人类基因治疗小组委员会的主席。他也是国会、行政部门以及关注新兴生物技术政策的学者们的常任顾问。很大程度上得益于沃尔特斯教授，肯尼迪伦理研究所成为了生物伦理领域主要的人才来源之一，其中包括那些任职于处理生殖和基因技术的政策与科学机构（如美国国立卫生研究院和技术评估办公室）的工作人员。他的遗产不仅体现在他的著作中，还体现在那些在美国指导了三十年生物技术政策的人员、文件和讨论之中。
